1. Introduction {#sec1-cancers-12-00507}
===============

Nasopharyngeal carcinoma (NPC) is a cancer with unique ethnic predisposition, Epstein--Barr virus (EBV) association, and morphologic features \[[@B1-cancers-12-00507]\]. NPC is uncommon among Caucasians, but its incidence is disproportionally high in certain ethnic groups, including Chinese from southeastern Asia, North Africans, and the Inuit. In endemic areas, including Taiwan, most cases of NPC are of the nonkeratinizing type with EBV association \[[@B1-cancers-12-00507],[@B2-cancers-12-00507],[@B3-cancers-12-00507]\]. Such nonkeratinizing NPC is characterized by undifferentiated or poorly differentiated carcinoma cells and a large number of admixed inflammatory cells, mainly small lymphocytes and plasma cells \[[@B1-cancers-12-00507]\]. These morphologic features could pose difficulty in pathologic diagnosis, especially for pathologists with less experience or in nonendemic areas.

Compared to other types of medical images, the microscopic images of pathology slides are much more complicated \[[@B4-cancers-12-00507]\]. There are multiple types of cells in a slide, and each cell type has its own morphologic characteristics, such as cell size and shape, cytoplasmic volume and features, nuclear size and shape, chromatin distribution, and number and size of nucleoli. Different cell types are then arranged in various patterns. In addition, the color and intensity of hematoxylin and eosin (H&E) staining could be influenced by subtle variations in tissue thickness and staining conditions among different laboratories, or even within a single laboratory. Furthermore, the digital files of high-resolution pathology images are extremely large in size and highly complicated, and computer analysis of such images is very difficult.

In recent years, deep neural networks have taken over as the dominant method for image recognition since their performance surpassed traditional image processing methods in the ImageNet Large Scale Visual Recognition Competition (ILSVRC) in 2012 \[[@B5-cancers-12-00507]\]. Deep neural networks achieve superior performance through a compute-intensive learning process. Using general-purpose computing on graphics processing units (GPGPU), the deep learning process can be highly accelerated \[[@B6-cancers-12-00507]\]. With tremendous success in recognition of natural images, convolutional neural networks have been quickly adopted for medical image analysis \[[@B7-cancers-12-00507]\]. Therefore, analysis of pathology images using artificial intelligence (AI) is becoming more feasible recently \[[@B8-cancers-12-00507],[@B9-cancers-12-00507],[@B10-cancers-12-00507],[@B11-cancers-12-00507],[@B12-cancers-12-00507],[@B13-cancers-12-00507],[@B14-cancers-12-00507],[@B15-cancers-12-00507],[@B16-cancers-12-00507],[@B17-cancers-12-00507],[@B18-cancers-12-00507],[@B19-cancers-12-00507]\]. Of note, a few articles described the success of AI in identifying metastatic breast cancer in lymph nodes \[[@B10-cancers-12-00507],[@B12-cancers-12-00507],[@B13-cancers-12-00507],[@B14-cancers-12-00507],[@B16-cancers-12-00507],[@B19-cancers-12-00507]\]. The performance of AI was comparable to that of pathologists without time constraints, and adopting AI assistance in the workflow can improve the diagnostic efficiency and accuracy of pathologists.

Nasopharyngeal mucosa has abundant lymphoid cells similar to lymph nodes, but there is an additional component of benign epithelial cells. Compared to metastatic breast cancer, the much lesser differentiation of tumor cells and the large number of admixed inflammatory cells in NPC could increase the difficulty in machine identification. It would be interesting to know if AI could perform well in a morphologically challenging cancer such as NPC.

2. Results {#sec2-cancers-12-00507}
==========

2.1. Patch-level Model {#sec2dot1-cancers-12-00507}
----------------------

During patch-level learning, we noticed that patches of benign nasopharynx with certain morphologic features, including germinal centers and benign epithelial cells, tended to be misclassified as NPC ([Figure 1](#cancers-12-00507-f001){ref-type="fig"}A--C). To prevent such misclassification, we added 5634 areas of benign epithelial cells and 1021 areas of germinal centers for patch-level learning. The retrained patch-level model successfully recognized germinal centers and benign epithelial cells as benign tissue ([Figure 1](#cancers-12-00507-f001){ref-type="fig"}D). The learning curves of our final patch-level model are shown in [Figure 2](#cancers-12-00507-f002){ref-type="fig"}A. The receiver operating characteristic (ROC) curves of our original and final patch-level models are shown in [Figure 2](#cancers-12-00507-f002){ref-type="fig"}B. The area under the ROC curve (AUC) showed significant increase (*p* = 0.000018) from 0.9675 ± 0.020 (original patch-level model) to 0.9900 ± 0.004 (final patch-level model).

2.2. Key Morphologic Features for Patch-level Identification {#sec2dot2-cancers-12-00507}
------------------------------------------------------------

The results of gradient-weighted class activation mapping for representative NPC patches are shown in [Figure 3](#cancers-12-00507-f003){ref-type="fig"}. The relatively important regions for our final patch-level NPC identification in each patch ([Figure 3](#cancers-12-00507-f003){ref-type="fig"}; red areas) were the locations of clearly identifiable cancer cells ([Figure 3](#cancers-12-00507-f003){ref-type="fig"}; arrows). Our result confirmed that the patch-level model did identify the morphologic features of NPC tumor cells.

2.3. Slide-level Model {#sec2dot3-cancers-12-00507}
----------------------

An example of our whole-slide image analyzed by our patch-level model is shown in [Figure 4](#cancers-12-00507-f004){ref-type="fig"}. Our patch-level model successfully identified areas of cancer cells ([Figure 4](#cancers-12-00507-f004){ref-type="fig"}D) with similarity to the areas identified by EBV-encoded small RNA (EBER) in situ hybridization ([Figure 4](#cancers-12-00507-f004){ref-type="fig"}C). More examples of NPC are shown in [Figure 5](#cancers-12-00507-f005){ref-type="fig"}. Despite the presence of many admixed lymphocytes ([Figure 5](#cancers-12-00507-f005){ref-type="fig"}; left panels), our patch-level model effectively identified tumor cells ([Figure 5](#cancers-12-00507-f005){ref-type="fig"}; right panels). The learning curves of our slide-level model are shown in [Figure 2](#cancers-12-00507-f002){ref-type="fig"}C. The ROC curve of our slide-level model is shown in [Figure 2](#cancers-12-00507-f002){ref-type="fig"}D. The AUC of our slide-level model was 0.9848.

The results of our human NPC identification, including sensitivity and specificity, are also shown in [Figure 2](#cancers-12-00507-f002){ref-type="fig"}D. The performance of our slide-level model was comparable to that of pathology residents (red crosses) but slightly worse than that of attending pathologists (blue crosses) and the chief resident (green cross).

3. Discussion {#sec3-cancers-12-00507}
=============

Here we show for the first time that deep convolutional neural networks can identify NPC, a cancer with little differentiation and many admixed inflammatory cells. Compared to previous studies identifying metastatic breast cancer in lymph nodes \[[@B10-cancers-12-00507],[@B12-cancers-12-00507],[@B13-cancers-12-00507],[@B14-cancers-12-00507],[@B16-cancers-12-00507],[@B19-cancers-12-00507]\], identification of NPC with AI is certainly a more difficult task. The tumor cells of NPC are mostly undifferentiated or poorly differentiated, resulting in more morphologic similarities to germinal center cells. In addition, the admixed inflammatory cells in NPC tumor cell clusters also increase the difficulty in machine identification. Most importantly, benign epithelial cells rarely appear in axillary lymph nodes (except for rare glandular inclusions \[[@B20-cancers-12-00507]\]), whereas most nasopharyngeal biopsies include benign epithelial cells, both on the surface and in the stroma. The distinction between malignant and benign epithelial cells is also a challenge.

Indeed, during our original patch-level learning, we found that the patch-level model tended to misclassify germinal centers and benign epithelial cells as NPC. Since only a small proportion of our original benign patches in the training set contained germinal centers and benign epithelial cells, the misclassification was likely due to under-representation of these areas in the training data. To overcome this, large numbers of areas containing germinal centers and benign epithelial cells were further annotated, and patches cropped from these areas were added into the training materials. The expansion of the training data with these patches successfully prevented the misclassification of germinal centers and benign epithelial cells as NPC ([Figure 1](#cancers-12-00507-f001){ref-type="fig"}).

Although deep neural networks can be used to identify images, it is difficult to know the exact morphologic features identified by the machine during complicated computations. Gradient-weighted class activation mapping is a useful tool to visualize the decision making in a deep neural network \[[@B21-cancers-12-00507]\]. It is known that deeper layers of a neural network identify more complicated structures \[[@B22-cancers-12-00507],[@B23-cancers-12-00507]\]. Utilizing the gradients flowing into the final layer, a coarse localization map highlighting the important areas for image classification can be produced. Using the gradient-weighted class activation mapping, we demonstrated that our patch-level model classifies patch images as NPC mainly according to the areas with clearly identifiable cancer cells ([Figure 3](#cancers-12-00507-f003){ref-type="fig"}).

The accuracy of our slide-level model was similar to that of our pathology residents but slightly worse than that of our attending pathologists ([Figure 2](#cancers-12-00507-f002){ref-type="fig"}D). For the few NPC cases misclassified as benign nasopharynx in our testing set, the tumor area percentage was very low (\<5%). Although these cases were missed by our slide-level model, the areas of cancer cells were successfully identified by our patch-level model. The relative paucity of NPC cases with a very low tumor percentage in our training set could explain these few failed cases in our slide-level model.

The development of deep learning algorithms to identify pathology images is largely hindered by the time-consuming manual annotation. Recently, a study showed that using multiple instance learning, a clinical-grade algorithm can be produced using a large dataset of whole-slide images without manual annotation \[[@B8-cancers-12-00507]\]. However, they used around 10,000 whole-slide images (9894 to 12,727 slides) in each dataset to develop an algorithm. For uncommon cancer types such as NPC, it is not feasible to obtain 10,000 cases for multiple instance learning. For now, high-quality manual annotation is inevitable to develop AI pathology for uncommon entities.

Since our images were manually annotated by a single senior pathologist, a bias due to personal subjectivity cannot be excluded. In addition, the color and intensity of H&E staining tend to differ among laboratories. Since our algorithms were developed using slides from a single laboratory, the accuracy could decrease for cases from other institutions. Expanding our training data with cases from other laboratories should help to achieve a more robust performance in the future.

It has been proposed that using AI as a screening tool, pathologists could exclude 65%--75% of slides but still retain 100% sensitivity \[[@B8-cancers-12-00507]\]. It is noteworthy that AI is usually trained for a specific task, and an answer outside the training set cannot be made by AI. For example, we cannot expect our algorithms to detect the rare cases of nasopharyngeal lymphoma, which was not included in our training data. It could be a safer approach to use AI as an assisting tool to highlight tumor areas for pathologists, since we might encounter rare tumors outside training sets in daily practice.

4. Materials and Methods {#sec4-cancers-12-00507}
========================

4.1. Case Selection {#sec4dot1-cancers-12-00507}
-------------------

A total of 726 nasopharyngeal biopsies (from the year 2015 to 2018), including 363 cases of NPC (354 non-keratinizing and 9 keratinizing) and 363 cases of benign nasopharyngeal tissue, were retrieved from the archives of Department of Pathology, Chang Gung Memorial Hospital in Linkou, Taiwan. For each case, one H&E slide was used. The H&E slides of all cases were reviewed by two senior pathologists (W.-Y.C. and C.H.) under a dual-head microscope to confirm the diagnosis. Whole-slide high-resolution digital images were produced using a NanoZoomer S360 digital slide scanner (Hamamatsu Photonics, Hamamatsu, Japan) with a 40× objective mode. The size of a whole-slide image was 179166 ± 25384 × 76096 ± 16180 pixels on average. We randomly selected 100 cases as the testing set, 20 cases as the validation set, and 606 other cases that were used as the training set. All three datasets had equal numbers of NPC cases and benign cases. This study had been approved by the Institutional Review Board of Chang Gung Memorial Hospital (IRB No. 201800287B0), Permission date (2 March 2018).

4.2. Computer Hardware and Softwares {#sec4dot2-cancers-12-00507}
------------------------------------

We performed our experiments on a customized server with 1× Nvidia Tesla P40 graphics processing unit (GPU). Our algorithms were developed with Python 3.6 and TensorFlow 1.12 on a Linux platform.

4.3. Patch-level Model {#sec4dot3-cancers-12-00507}
----------------------

Areas of NPC, benign nasopharynx, and background were annotated by a senior pathologist (W.-Y.C.) using a free-hand region-of-interest tool on the aetherAI digital pathology platform (aetherAI, Taipei, Taiwan). The annotation was mainly based on morphology of the H&E images. For difficult cases, the results of cytokeratin immunostaining and/or EBER in situ hybridization were used as assistance. The total numbers of annotated free-hand areas of NPC, benign tissue, and background (areas without tissue) were 6548, 10,165, and 62, respectively. For the improvement of patch-level learning, 5634 areas of benign epithelium and 1021 areas of germinal centers were subsequently annotated.

For patch-level training, validation, and testing, square image patches of 256 × 256 pixels were randomly and dynamically cropped from the free-hand annotated areas. For patches of background and benign tissue, the cropped patches must be 100% within the annotated region. For NPC patches, at least 50% of the patch area must be within the annotated tumor region. For each class (NPC, benign tissue or background), around 840,000 patches were sampled.

Our patch-level training was performed using ResNeXt, a deep neural network with a residual and inception architecture \[[@B24-cancers-12-00507],[@B25-cancers-12-00507],[@B26-cancers-12-00507]\]. We initialized the kernel weights from existing models pretrained on another domain. Along with the training progress, the kernel weights were gradually updated with the process called stochastic gradient descent (SGD) \[[@B27-cancers-12-00507]\], which repeated millions of times. We used the SGD optimizer with the Nesterov momentum \[[@B28-cancers-12-00507]\] (with an initial learning rate of 0.0017 and a momentum of 0.95) to train the model and evaluated the performance per 1000 training steps. A batch size of balanced 48 patches (16 each of NPC, benign tissue, and background) was used to train the model. We used a scheme to reduce the learning rate on plateau.

To compare the ROC curves of our original and final patch-level models, we repeated the testing inference process 30 times. In each testing run, the two models predicted the same randomly taken 16,000 testing patches. The mean and variance of AUC of the two models were calculated. The performance of the two models was compared using a two-tailed *t*-test.

4.4. Gradient-weighted Class Activation Mapping {#sec4dot4-cancers-12-00507}
-----------------------------------------------

We used gradient-weighted class activation mapping \[[@B21-cancers-12-00507]\] to visualize relatively important regions for model prediction in a patch. Briefly, a localization map of important regions in the patch was produced using the gradient information flowing into the final layer of the neural network \[[@B21-cancers-12-00507]\].

4.5. Slide-level Model {#sec4dot5-cancers-12-00507}
----------------------

All of our 726 whole-slide images were sequentially cropped into patches of 256 × 256 pixels without overlapping, and each patch was inferred with the patch-level algorithm. The inferred results were reconstructed into a whole-slide image of a smaller size, with each pixel containing three channels: probability of NPC, benign tissue, and background. The reconstructed images were used for training (606 images in the training set), validation (20 images in the validation set), and testing (100 images in the testing set).

Due to variation in image size among slides, we resized inputs into certain shapes per batch. The target sizes included 256 × 256, 256 × 512, 256 × 768, 512 × 768, 400 × 600, and 500 × 500 pixels. Resizing inputs into different target sizes per batch worked as data augmentation and improved the model generalization. We combined the inferred probability maps and corresponding low-resolution whole slide images and utilized a residual network ResNet \[[@B25-cancers-12-00507]\] to train the slide-level model with free input sizes. The advantage of using free size input is that any given slide can be verified multiple times under different aspect ratios. During the training process, we used the SGD optimizer with the Nesterov momentum \[[@B28-cancers-12-00507]\] (with an initial learning rate of 0.0017 and a momentum of 0.95) and set a balanced batch size of 8 (4 each of NPC and benign nasopharynx). A scheme to reduce the learning rate on plateau was also used to optimize the model performance.

4.6. Comparison with Human Performance {#sec4dot6-cancers-12-00507}
--------------------------------------

Four attending pathologists (C.-J.Y., S.-H.U., T.-D.C., and K.-H.C.), one chief resident (Y.-J.L.), and two residents (Y.-Y.H. and Y.H.) from the Department of Pathology, Chang Gung Memorial Hospital in Linkou participated in this comparison. The 100 H&E slides of the testing set were reviewed under a microscope by each participant without time constraints. The slides of auxiliary studies, such as immunohistochemistry and in situ hybridization, were not provided. For each participant, the total slide review process took 43 to 58 min, with a median of 54 min. The sensitivity and specificity of human reviewers were compared with those of our slide-level model produced by deep learning.

5. Conclusions {#sec5-cancers-12-00507}
==============

In the present study, we have developed for the first time deep learning algorithms to identify NPC in nasopharyngeal biopsies. Despite the lack of tumor cell differentiation and the abundance of admixed inflammatory cells in NPC, we show that deep learning can overcome these difficulties. Expansion of the training data with misclassified patches can improve the patch-level performance, and gradient-weighted class activation mapping is helpful to confirm the morphologic features used in machine identification.
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![Expansion of the training data successfully prevented misclassification of patches. (**A**) An example of benign nasopharyngeal tissue in our testing set, with prominent germinal centers (G) and benign epithelial cells (asterisks) (original magnification ×40). (**B**) A magnified inset of (**A**) (dotted square). (**C**) The original patch-level model misclassified regions of germinal centers and benign epithelial cells as nasopharyngeal carcinoma (red color: high probability). (**D**) The performance of the model was markedly improved after expanding the training data with germinal centers and benign epithelial cells.](cancers-12-00507-g001){#cancers-12-00507-f001}

![The learning curves and receiver operator characteristic (ROC) curves of our algorithms. (**A**) The learning curves of our final patch-level model. (**B**) The ROC curves of our patch-level models. The area under ROC curve (AUC) increased from 0.9675 ± 0.020 to 0.9900 ± 0.004 after expanding the training data with germinal centers and benign epithelial cells (*p* = 0.000018). (**C**) The learning curves of our slide-level model. (**D**) The ROC curve of our slide-level model. The results of pathology residents (red crosses), chief resident (green cross), and attending pathologists (blue crosses) were included for comparison.](cancers-12-00507-g002){#cancers-12-00507-f002}

![Results of gradient-weighted class activation mapping (Grad-CAM) on patches (256 × 256 pixels) classified as nasopharyngeal carcinoma (NPC) by our patch-level model. The lower row is the result of Grad-CAM, and the upper row is the corresponding hematoxylin and eosin (H&E) images for comparison. The numbers above each H&E image represent the probability of NPC produced by our patch-level algorithm. Note that the most important region (red color) for classifying a patch as NPC correlated with the location of a clearly identifiable cancer cell (arrows).](cancers-12-00507-g003){#cancers-12-00507-f003}

![Correlation between our patch-level model and Epstein--Barr virus (EBV)-encoded small RNA (EBER) in situ hybridization. (**A**) An example of nasopharyngeal carcinoma in our testing set (original magnification ×40). (**B**) A magnified inset of (**A**) (dotted square). Note the tumor cells (T), lymphoid stroma (L), and benign epithelium (E). (**C**) The tumor cells were highlighted by EBER in situ hybridization. (**D**) The tumor areas identified by our patch-level model (red color: high probability) correlated well with (**C**).](cancers-12-00507-g004){#cancers-12-00507-f004}

![Correlation between our patch-level model and H&E morphology. More examples of nasopharyngeal carcinoma in our testing set. Each right image is derived from the left corresponding H&E image using our patch-level model (original magnification ×100). Despite the large number of admixed lymphocytes, the tumor cells were successfully identified by our patch-level mode (red color: high probability). Note that the germinal centers (G) and benign epithelial cells (arrowheads) were correctly classified as benign.](cancers-12-00507-g005){#cancers-12-00507-f005}
